|
Volumn 20, Issue 2, 2000, Pages 89-93
|
Efficacy and safety of quinfamide versus secnidazole in the management of amoebic non-dysenteric colitis in children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMEFIN;
ANTIAMEBIC AGENT;
QUINFAMIDE;
SECNIDAZOLE;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADOLESCENT;
AMEBIASIS;
ARTICLE;
CHILD;
CLINICAL TRIAL;
COLITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
ENTAMOEBA HISTOLYTICA;
FECES ANALYSIS;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEXICO;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VOMITING;
|
EID: 0033858563
PISSN: 11732563
EISSN: None
Source Type: Journal
DOI: 10.2165/00044011-200020020-00003 Document Type: Article |
Times cited : (8)
|
References (19)
|